Outsourced Clinical Trials & Formulation Market Is Estimated to Expand at a CAGR of 6.7% over the Forecast Period (2022-2032)
Oral dosage form dominates the product segment in terms of revenue and accounted for more than 61% market share in 2021.
View full press release